ZA973964B - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- ZA973964B ZA973964B ZA973964A ZA973964A ZA973964B ZA 973964 B ZA973964 B ZA 973964B ZA 973964 A ZA973964 A ZA 973964A ZA 973964 A ZA973964 A ZA 973964A ZA 973964 B ZA973964 B ZA 973964B
- Authority
- ZA
- South Africa
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9609794.4A GB9609794D0 (en) | 1996-05-10 | 1996-05-10 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA973964B true ZA973964B (en) | 1998-11-09 |
Family
ID=10793494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA973964A ZA973964B (en) | 1996-05-10 | 1997-05-08 | Novel compounds |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6235753B1 (es) |
| EP (1) | EP0918747B1 (es) |
| JP (1) | JP2000510473A (es) |
| KR (1) | KR20000010892A (es) |
| AR (1) | AR007060A1 (es) |
| AT (1) | ATE246673T1 (es) |
| AU (1) | AU2897397A (es) |
| BR (1) | BR9709450A (es) |
| CA (1) | CA2253590A1 (es) |
| CO (1) | CO4990945A1 (es) |
| CZ (1) | CZ363198A3 (es) |
| DE (1) | DE69723984T2 (es) |
| ES (1) | ES2205218T3 (es) |
| GB (1) | GB9609794D0 (es) |
| IL (1) | IL126860A0 (es) |
| NO (1) | NO985214L (es) |
| NZ (1) | NZ332628A (es) |
| PL (1) | PL329855A1 (es) |
| TR (1) | TR199802271T2 (es) |
| WO (1) | WO1997043249A1 (es) |
| ZA (1) | ZA973964B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020082200A1 (en) * | 1994-07-13 | 2002-06-27 | Smithkline Beecham P.1.C. | Use of inhibitors of human S-CD23 |
| US6548084B2 (en) | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
| AUPO721997A0 (en) * | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
| ATE286892T1 (de) | 1997-11-12 | 2005-01-15 | Darwin Discovery Ltd | Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität |
| GB9813451D0 (en) * | 1998-06-22 | 1998-08-19 | Smithkline Beecham Plc | Novel compounds |
| GB9922825D0 (en) * | 1999-09-25 | 1999-11-24 | Smithkline Beecham Biolog | Medical use |
| KR20020070285A (ko) | 1999-11-23 | 2002-09-05 | 메틸진, 인크. | 히스톤 디아세틸라제의 억제제 |
| GB9930754D0 (en) * | 1999-12-29 | 2000-02-16 | Smithkline Beecham Plc | Novel compounds |
| CA2516842A1 (en) * | 2003-02-25 | 2004-09-10 | Topotarget Uk Limited | Hydroxamic acid compounds comprising a bicylic heteroaryl group as hdac inhibitors |
| GB0818907D0 (en) * | 2008-10-15 | 2008-11-19 | Isis Innovation | Histone lysine demethylase inhibitors |
| CA2763565A1 (en) | 2009-05-28 | 2010-12-02 | Novartis Ag | Substituted aminobutyric derivatives as neprilysin inhibitors |
| ES2523734T3 (es) * | 2009-05-28 | 2014-12-01 | Novartis Ag | Derivados aminopropiónicos sustituidos como inhibidores de neprilisina |
| US8945575B2 (en) | 2009-12-01 | 2015-02-03 | Trustees Of Boston University | Treatment of IgE-mediated disease |
| CN105008337B (zh) | 2013-02-14 | 2017-08-04 | 诺华股份有限公司 | 具有改善的体内功效的作为nep抑制剂的取代的联苯基丁酸衍生物 |
| LT2956464T (lt) | 2013-02-14 | 2018-07-10 | Novartis Ag | Pakeisti bisfenilbutanoinės fosfonrūgšties dariniai, kaip nep (neutralios endopeptidazės) inhibitoriai |
| CA2963875A1 (en) * | 2014-11-19 | 2016-05-26 | Actelion Pharmaceuticals Ltd | Antibacterial benzothiazole derivatives |
| CA3115038A1 (en) | 2018-10-04 | 2020-04-09 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Egfr inhibitors for treating keratodermas |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
| DE69515702T2 (de) * | 1994-01-20 | 2000-08-10 | British Biotech Pharm | L-Tertiär-leucin-2-pyridylamid |
| GB9414157D0 (en) * | 1994-07-13 | 1994-08-31 | Smithkline Beecham Plc | Medical use |
| US5562917A (en) | 1994-12-23 | 1996-10-08 | Pentech Pharmaceuticals, Inc. | Transdermal administration of apomorphine |
| DE19506492C2 (de) | 1995-02-24 | 2003-05-08 | Focke & Co | Einrichtung zum Speichern von Zigaretten oder dergleichen |
| US5570079A (en) | 1995-04-24 | 1996-10-29 | Dockery; Devan | Home security system for detecting an intrusion into a monitored area by an infrared detector |
-
1996
- 1996-05-10 GB GBGB9609794.4A patent/GB9609794D0/en active Pending
-
1997
- 1997-05-06 AT AT97923064T patent/ATE246673T1/de not_active IP Right Cessation
- 1997-05-06 PL PL97329855A patent/PL329855A1/xx unknown
- 1997-05-06 AU AU28973/97A patent/AU2897397A/en not_active Abandoned
- 1997-05-06 BR BR9709450A patent/BR9709450A/pt not_active Application Discontinuation
- 1997-05-06 CZ CZ983631A patent/CZ363198A3/cs unknown
- 1997-05-06 EP EP97923064A patent/EP0918747B1/en not_active Expired - Lifetime
- 1997-05-06 NZ NZ332628A patent/NZ332628A/en unknown
- 1997-05-06 DE DE69723984T patent/DE69723984T2/de not_active Expired - Fee Related
- 1997-05-06 WO PCT/EP1997/002433 patent/WO1997043249A1/en not_active Application Discontinuation
- 1997-05-06 IL IL12686097A patent/IL126860A0/xx unknown
- 1997-05-06 ES ES97923064T patent/ES2205218T3/es not_active Expired - Lifetime
- 1997-05-06 KR KR1019980709039A patent/KR20000010892A/ko not_active Application Discontinuation
- 1997-05-06 US US09/180,547 patent/US6235753B1/en not_active Expired - Fee Related
- 1997-05-06 TR TR1998/02271T patent/TR199802271T2/xx unknown
- 1997-05-06 JP JP09540514A patent/JP2000510473A/ja not_active Ceased
- 1997-05-06 CA CA002253590A patent/CA2253590A1/en not_active Abandoned
- 1997-05-08 ZA ZA973964A patent/ZA973964B/xx unknown
- 1997-05-08 AR ARP970101926A patent/AR007060A1/es not_active Application Discontinuation
- 1997-05-09 CO CO97025078A patent/CO4990945A1/es unknown
-
1998
- 1998-11-09 NO NO985214A patent/NO985214L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL329855A1 (en) | 1999-04-12 |
| CA2253590A1 (en) | 1997-11-20 |
| BR9709450A (pt) | 1999-08-10 |
| KR20000010892A (ko) | 2000-02-25 |
| AR007060A1 (es) | 1999-10-13 |
| NO985214L (no) | 1998-12-01 |
| CZ363198A3 (cs) | 1999-06-16 |
| ATE246673T1 (de) | 2003-08-15 |
| DE69723984T2 (de) | 2004-06-09 |
| EP0918747B1 (en) | 2003-08-06 |
| NZ332628A (en) | 2000-06-23 |
| NO985214D0 (no) | 1998-11-09 |
| AU2897397A (en) | 1997-12-05 |
| WO1997043249A1 (en) | 1997-11-20 |
| IL126860A0 (en) | 1999-09-22 |
| JP2000510473A (ja) | 2000-08-15 |
| US6235753B1 (en) | 2001-05-22 |
| EP0918747A1 (en) | 1999-06-02 |
| GB9609794D0 (en) | 1996-07-17 |
| TR199802271T2 (xx) | 2000-08-21 |
| DE69723984D1 (de) | 2003-09-11 |
| CO4990945A1 (es) | 2000-12-26 |
| ES2205218T3 (es) | 2004-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0914330A4 (en) | NEW TYPE COMPOUNDS | |
| EP0961618A4 (en) | NEW COMPOUNDS | |
| EP0909181A4 (en) | NEW COMPOUNDS | |
| GB9601067D0 (en) | Novel compounds | |
| EP0907376A4 (en) | NEW CONNECTIONS | |
| GB9609794D0 (en) | Novel compounds | |
| AP9701047A0 (en) | Novel compounds | |
| GB9605945D0 (en) | Novel compounds | |
| GB9600955D0 (en) | Novel compounds | |
| AP9701037A0 (en) | Novel compounds | |
| GB9601041D0 (en) | Novel compounds | |
| GB9604045D0 (en) | Novel compounds | |
| GB9605381D0 (en) | Novel compounds | |
| GB9605883D0 (en) | Novel compounds | |
| EP0954525A4 (en) | NEW CONNECTIONS | |
| GB9601068D0 (en) | Novel compounds | |
| EP0907377A4 (en) | NEW CONNECTIONS | |
| GB9601099D0 (en) | Novel compounds | |
| GB9601066D0 (en) | Novel compounds | |
| GB9605155D0 (en) | Novel compounds | |
| GB9604582D0 (en) | Novel compounds | |
| GB9606198D0 (en) | Novel compounds | |
| GB9603689D0 (en) | Novel compounds | |
| GB9605153D0 (en) | Novel compounds | |
| GB9604599D0 (en) | Novel compounds |